GWS
STIM icon

Glassman Wealth Services’s Neuronetics STIM Stock Holding History

Glassman Wealth Services’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-62
Closed – – 1901
2021
Q3 		$0 Buy
+62
New +$595 ﹤0.01% 1798

Other funds holding STIM

CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

Glassman Wealth Services's STIM Position: Q4 2021 in Review

Glassman Wealth Services sold out of Neuronetics (STIM) in Q4 2021, closing a stake of 62 shares.

Glassman Wealth Services first reported a position in STIM in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 80 funds tracked by Wall St. Rank hold STIM as of Q4 2021.

  • Glassman Wealth Services reported no remaining Neuronetics position as of Q4 2021 after selling out during the quarter.
  • Glassman Wealth Services sold 62 Neuronetics shares in Q4 2021.
  • Glassman Wealth Services first reported a position in Neuronetics in Q3 2021 and held it in 1 quarter.
  • Glassman Wealth Services's Neuronetics position peaked at $0 in Q3 2021.
  • 80 funds tracked by Wall St. Rank held Neuronetics as of Q4 2021.

Based on Glassman Wealth Services's 13F filing for Q4 2021, filed 14 Feb 2022.